Psoriasis induced by infliximab;Psoríase induzida por infliximab

Acta Medica Portuguesa

Volumn 24, Issue SUPPL.3, 2011, Pages 709-712

  Fernandes, Iolanda C ^a   Torres, Tiago ^a   Sanches, Madalena ^a   Velho, Glória ^a   Lago, Paula ^a   Selores, Manuela ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; DRUG WITHDRAWAL; ERYTHEMA; HUMAN; MALE; PSORIASIS; SKIN BIOPSY;

ADULT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; PSORIASIS;

EID: 84863305518     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. VIGUIER M, RICHETTE P, BACHELEZ H et al: Paradoxical adverse effects of anti-TNF-alpha treatment: onset or exacerbation of cutaneous disorders. Expert Rev Clin Immunol 2009;5(4):421-431
2. G. FIORINO, M. ALLEZ, A. MALESCI et al: Review article: TNF-a induced psoriasis in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2009;29:921-927
3. KO JM, GOTTLIEB AB, KERBLESKI JF: Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases. J Dermatolog Treat 2009;20(2):100-108
4. UWE WOLLINA, GESINA HANSEL, ANDRÉ KOCH et al: Tumor Necrosis Factor-a Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata. Am J Clin Dermatol 2008;9(1):1-14
5. WINTERFIELD LS, MENTER A: Infliximab. Dermatol Ther 2004;17:409-426
6. MJ Harrison, WG Dixon, KD Watson et al. and the British Society for Rheumatology Biologics Register Control Centre Consortium, on behalf of the BSRBR: Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumor necrosis factor a therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2009;68:209-215
7. DE GANNES GC, GHOREISHI M, POPE J et al: Psoriasis and pustular dermatitis triggered by TNF-alpha inhibitors in patients with rheumatologic conditions. Arch Dermatol 2007;143:223-231
8. AEBERLI D, SEITZ M, JUNI P et al: Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-a inhibitors. Rheumatology 2005;44:172-175
9. LADOYANNI E, NAMBI R: Psoriasis exacerbated by interferonalpha in a patient with chronic myeloid leukemia. J Drugs Dermatol 2005;4(2):221-222
10. MICHAËLSSON G, KAJERMO U, MICHAËLSSON A et al: Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumor necrosis factor-a in the normal palmar eccrine sweat duct? Br J Dermatol 2005;153:1243-1244